When Michael Sen took over as chief executive of Fresenius at the start of this month, he knew he was facing some big challenges. Now, a few weeks into the job, he is seeking a “reset” of the debt-laden healthcare group, amid speculation it may be under pressure to break up.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,